Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Vaccinations01:51

Vaccinations

Overview
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

The health and economic repercussions of declining MMR coverage in the United States.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Estimating US savings on outpatient prescription pharmaceuticals from international reference pricing.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

The synergy of therapeutic vaccination and timely diagnosis for TB control in high-burden settings: Nunavut as a case study.

Journal of clinical tuberculosis and other mycobacterial diseases·2025
Same author

Racial and Ethnic Disparities in Meningococcal Vaccination Coverage and Disease Burden Among U.S. Adolescents.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine·2025
Same author

Quantifying the mortality and morbidity impact of medicaid work requirements: a modeling study.

Lancet regional health. Americas·2025
Same author

School-Level Gaps in MMR Coverage as the Fuel for Measles Outbreaks.

Annals of internal medicine·2025
Same journal

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Science (New York, N.Y.)·2026
Same journal

Local signals, systemic decline.

Science (New York, N.Y.)·2026
Same journal

The mechanics of liver regeneration.

Science (New York, N.Y.)·2026
Same journal

Computing in a memory with physics.

Science (New York, N.Y.)·2026
Same journal

Retraction.

Science (New York, N.Y.)·2026
Same journal

Making time.

Science (New York, N.Y.)·2026
関連記事をすべて見る

関連する実験動画

Updated: Jun 20, 2026

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

インフルエンザワクチンの流通を最適化

Jan Medlock1, Alison P Galvani

  • 1Epidemiology and Public Health, Yale University School of Medicine, 60 College Street, New Haven, CT 06520-8034, USA. medlock@clemson.edu

Science (New York, N.Y.)
|August 22, 2009
PubMed
まとめ
この要約は機械生成です。

インフルエンザワクチンの配給を最適化するには,学校の子供と30~39歳の成人を優先する必要があります. この戦略は,主要な感染群をターゲットにすることで,死亡,感染,および経済的コストを最小限に抑えます.

さらに関連する動画

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

Optimization of a Quantitative Micro-neutralization Assay
10:09

Optimization of a Quantitative Micro-neutralization Assay

Published on: December 14, 2016

関連する実験動画

Last Updated: Jun 20, 2026

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

Optimization of a Quantitative Micro-neutralization Assay
10:09

Optimization of a Quantitative Micro-neutralization Assay

Published on: December 14, 2016

科学分野:

  • 公衆衛生は公衆衛生である.
  • エピデミオロジー エピデミオロジー
  • 健康経済学 医療経済学

背景:

  • 効果的な公衆衛生政策は,最適化のための堅実な評価基準に依存しています.
  • インフルエンザのパンデミックは,公衆衛生と経済に重大なリスクをもたらします.
  • ワクチンの配給戦略は,インフルエンザの影響を軽減するために非常に重要です.

研究 の 目的:

  • 最適なインフルエンザワクチンの配給戦略を決定する.
  • 政策の最適化のためのさまざまな成果測定を評価する.
  • モデルベースの勧告を既存のガイドラインと比較する.

主な方法:

  • 調査に基づく接触データと死亡率データを用いて数学的モデルが開発されました.
  • このモデルは,インフルエンザのパンデミックシナリオをシミュレートした.
  • 最適なワクチンの配分は,5つの異なる結果指標で評価されました.

主要な成果:

  • 30歳から39歳までの学童や成人を優先することは,死亡,感染,経済的コストを減らすのに最適です.
  • 学校の生徒は,インフルエンザの感染の主な原動力として特定されています.
  • 既存の米国疾病管理予防センターの勧告は,最適以下であることが判明しました.

結論:

  • インフルエンザワクチンの有効な配給には,年齢特有の伝播ダイナミクスが不可欠です.
  • 学校の子供とその親をターゲットにすることで,病気の蔓延を大幅に減らすことができます.
  • 政策の最適化には,静的な勧告を超えて,ダイナミックな評価が必要です.